Pee Dee Cardiology Selects Allscripts Professional Electronic Health Record and Practice Management Solution.
CHICAGO and FLORENCE, S.C., Feb. 19 /PRNewswire-FirstCall/ -- Allscripts announced today that Pee Dee Cardiology Associates has selected Allscripts Professional Electronic Health Record (EHR) and Practice Management (PM) for its 16 clinicians in the Pee Dee River region of South Carolina. The agreement continues Pee Dee's longstanding partnership with...

The American College of Cardiology Renews its Publishing Partnership With Elsevier.
NEW YORK, January 8 /PRNewswire-FirstCall/ -- Elsevier, the leading publisher of medical and scientific literature, announced today that it renewed its publishing partnership with the American College of Cardiology (ACC) (http://www.acc.org/), the leading nonprofit medical society in the field of cardiovascular research. The agreement calls for Elsevier to publish...

Prism Pharmaceuticals' Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology.
- First time IV formulation of clopidogrel, the active ingredient in PLAVIX(R), is studied in humans - KING OF PRUSSIA, Pa., Feb. 9 /PRNewswire/ -- Prism Pharmaceuticals announced today that the results of the first-in-man study of PM103, a novel intravenous formulation of clopidogrel bisulfate (the active...

Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting.
First Release of PROTECT AF Trial Results on WATCHMAN(R) LAA Closure Technology MINNEAPOLIS, Feb. 19 /PRNewswire/ -- Atritech, Inc. announced the upcoming presentation of the PROTECT AF trial results comparing the WATCHMAN(R) Left Atrial Appendage (LAA) Closure Device to the current standard of care, warfarin therapy, in...

Emageon Signs Agreement with Integrated Health Network MultiCare.
MultiCare Health System to go fully digital with Emageon's cardiac PACS and hemodynamic reporting BIRMINGHAM, Ala., Jan. 20 /PRNewswire-FirstCall/ -- Emageon, a leader in enterprise medical information technology systems for hospitals and health care networks, announced today that it has been awarded a five-year HeartSuite(TM) VERICIS(R) cardiology...

MEDICAL MEMOS.
COLUMN: MEDICAL MEMOS Paula Hutchinson has joined the St. Vincent Hospital team as the new associate director of infection control. Susan Dunn, RN, BSN, has accepted the position of nursing director of invasive and non-invasive cardiology at St. Vincent Hospital. Lisa Holmgren, RN,...

Boston Scientific and Medtronic Reach Agreement on Patent Disputes.
Agreement stops all litigation in interventional cardiology and endovascular repair NATICK, Mass., Jan. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation and Medtronic, Inc. today announced the settlement of two lawsuits and an agreement to stand down in three others. These agreements stop all current litigation between the two...

Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use.
Nearly 150,000 PCIs Were Performed on AMI Patients in 2008, According to Millennium Research Group WALTHAM, Mass., Feb. 18 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Interventional Cardiology Devices 2009 report, the use of drug-eluting stents will continue to climb steadily through 2013,...

Traditional Risk Factors Often Miss Heart Disease Warning Signs.
VAP(R) Cholesterol Test helps physicians identify emerging risk factors better than standard cholesterol test and traditional risk factors, study shows BIRMINGHAM, Ala., Jan. 30 /PRNewswire/ -- Traditional risk factors such as age, standard cholesterol levels and blood pressure do a poor job of predicting heart disease risk...

Cardiovascular risk data clarify glycemic targets.
The target hemoglobin [A.sub.1c] of less than 7% should remain the general goal for nonpregnant adults with diabetes, despite recent results from three large randomized trials showing that intensive glucose lowering did not reduce the risks of cardiovascular disease in people with longstanding type 2 diabetes. But...